RNS Number:5544N
CeNeS Pharmaceuticals PLC
15 July 2003

                                        
                            CeNeS Pharmaceuticals Plc
                                        
                                        
  Notice of AGM, proposed Sub-division of share capital and Annual Report and
                  Accounts for the year ended 31 December 2002



CeNeS Pharmaceuticals Plc ("CeNeS" or the "Company") announces that its Annual
General Meeting ("AGM") is due to take place on 11 August 2003 at 11.00 a.m.


The Board of CeNeS also announces that it has today sent a circular ("Circular")
to its shareholders containing information on the proposed sub-division of its
existing ordinary share capital of 10p each to new ordinary shares of 1p each
("Sub-division"). The new ordinary shares will effectively have the same rights
as each existing ordinary 10p shares and provide the Board with additional
flexibility to issue new stock in the future. The Sub-division requires the
approval of CeNeS' shareholders at a general meeting which is proposed to take
place at the AGM.


Copies of the above Circular, together with the 2002 annual report and accounts
are being submitted to the UKLA, and will shortly be available for inspection at
the UKLA's Document Viewing Facility, which is situated at:


Financial Services Authority

25 The North Colonnade

Canary Wharf

London

E14 5HS

Tel. 020 7676 1000



15 July 2003











Enquiries:

CeNeS Pharmaceuticals Plc                                        01223 266 466
Neil Clark







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
NOASFESUISDSELW